Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > More POSITIVE news just out!!

<< Previous

Bullboard Posts

Next >>

Comment by Stockfshron Jun 06, 2022 5:19pm

188 Views

Post# 34735334

RE:RE:More POSITIVE news just out!!

I am not sure immunosuppression is continuing to have issues in the other three patients, Bio. News release states: "Three additional patients on study did not maintain optimal immunosuppression, which has now been resolved enabling those patients to receive further protocol-defined islet transplants."
But for sure immunosuppression via conformal coating or gene editing is becoming the next hurdle to overcome.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments